Cargando…
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603755/ http://dx.doi.org/10.1186/2052-3211-8-S1-P1 |
_version_ | 1782394950736936960 |
---|---|
author | Fraeyman, Jessica De Loof, Hans Van Hal, Guido De Meyer, Guido Remmen, Roy Beutels, Philippe |
author_facet | Fraeyman, Jessica De Loof, Hans Van Hal, Guido De Meyer, Guido Remmen, Roy Beutels, Philippe |
author_sort | Fraeyman, Jessica |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4603755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46037552015-10-14 Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin Fraeyman, Jessica De Loof, Hans Van Hal, Guido De Meyer, Guido Remmen, Roy Beutels, Philippe J Pharm Policy Pract Poster Presentation BioMed Central 2015-10-05 /pmc/articles/PMC4603755/ http://dx.doi.org/10.1186/2052-3211-8-S1-P1 Text en Copyright © 2015 Fraeyman et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Fraeyman, Jessica De Loof, Hans Van Hal, Guido De Meyer, Guido Remmen, Roy Beutels, Philippe Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin |
title | Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin |
title_full | Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin |
title_fullStr | Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin |
title_full_unstemmed | Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin |
title_short | Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin |
title_sort | unintended consequences of co-payment regulations in belgium: the case of atorvastatin |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603755/ http://dx.doi.org/10.1186/2052-3211-8-S1-P1 |
work_keys_str_mv | AT fraeymanjessica unintendedconsequencesofcopaymentregulationsinbelgiumthecaseofatorvastatin AT deloofhans unintendedconsequencesofcopaymentregulationsinbelgiumthecaseofatorvastatin AT vanhalguido unintendedconsequencesofcopaymentregulationsinbelgiumthecaseofatorvastatin AT demeyerguido unintendedconsequencesofcopaymentregulationsinbelgiumthecaseofatorvastatin AT remmenroy unintendedconsequencesofcopaymentregulationsinbelgiumthecaseofatorvastatin AT beutelsphilippe unintendedconsequencesofcopaymentregulationsinbelgiumthecaseofatorvastatin |